Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1.

He, Ling; Ioannidis, Angeliki; Arambula, Evelyn; Hoffman, Carter J; Joshi, Purva; Kathiravan, Anoushka; Whitelegge, Julian; Liau, Linda M; Kornblum, Harley I; Pajonk, Frank

He, Ling; Ioannidis, Angeliki; Arambula, Evelyn; Hoffman, Carter J; Joshi, Purva; Kathiravan, Anoushka; Whitelegge, Julian; Liau, Linda M; Kornblum, Harley I; Pajonk, Frank.

Afiliação

He L; Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Ioannidis A; Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Arambula E; Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Hoffman CJ; Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Joshi P; Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Kathiravan A; Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Whitelegge J; Jonsson Comprehensive Cancer Center at UCLA.
Liau LM; Department of Psychiatry and Human Behavior, David Geffen School of Medicine at UCLA.
Kornblum HI; Jonsson Comprehensive Cancer Center at UCLA.
Pajonk F; Department of Neurosurgery, David Geffen School of Medicine at UCLA.

bioRxiv ; 2023 Jul 25.

Article em En | MEDLINE | ID: mdl-37546917

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google